Which of the following statement is false about drugs used in rheumatoid ahritis?: (A) Tofacitinib inhibits JAK1 and JAK3, (B) Tocilizumab inhibits IL-6, (C) Tofactinib is given intravenously, (D) Tocilizumab is given by intravenous and subcutaneous route
Answer is C. Drug ending with inib - JAK inhibitor and given orally.- Tofacitinib- Beracitinib Drug ending with Mab: - Monoclonal antibody and IL-6 inhibitor.- Tocilizumab- SarilumabSix : IL-6A-AhritisR-RheumatoidI - InterleukinL - InterleukinUMAB: Monoclonal Antibody.All above mentioned drugs are used for Rheumatoid ahritis. Tocilizumab: is also use for cytokine release syndrome.